PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
4 hedge funds and large institutions have $7.12M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
27% less capital invested
Capital invested by funds: $9.78M → $7.12M (-$2.66M)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $3.34M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $3.34M | – | – | – |
|
|
PF
3
Phoenix Financial
Givatayim,
Israel
| $365K | – | – | – |
|
4
Millennium Management
New York
| $82K | – | – | – |
|
PHXM Hedge Fund Activity: Q1 2020 in Review
4 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2020, worth a combined $7.12M — down 27% from $9.78M a quarter earlier.
Fund positioning in PHXM was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 4 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $7.12M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2020, down 27% quarter-over-quarter.
- 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2020 and 0 closed out.
Based on aggregated 13F filings for Q1 2020.